{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:00:18Z","timestamp":1790715618609,"version":"4.1.0"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01949","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:41:35Z","timestamp":1596760895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":389,"title":["Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past"],"prefix":"10.3389","volume":"11","author":[{"given":"Vibhuti Kumar","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Firmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipyaman","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samit","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jama.2020.3227","article-title":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient","volume":"323","author":"Ong","year":"2020","journal-title":"JAMA - J Am Med Assoc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS : recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019 : a model-based analysis","volume":"3099","author":"Verity","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B6","unstructured":"Vol142020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1126\/science.1085952","article-title":"The genome sequence of the sars-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"3405","author":"Zhang","year":"2020","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"2","author":"Yan","year":"2020","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus\u2013host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases."},{"key":"B14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses."},{"key":"B16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.25719","article-title":"COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis","volume":"92","author":"Angeletti","year":"2020","journal-title":"J Med Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/cid\/ciaa112","article-title":"Origin and evolution of the 2019 novel coronavirus","volume":"71","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J Transl Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","volume":"83","author":"van Dorp","year":"2020","journal-title":"Infect Genet Evol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Wenhui","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1007236","article-title":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2","volume":"14","author":"Song","year":"2018","journal-title":"PLoS Pathog."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.aax0902","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"B26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4615-1899-0_58","article-title":"Localization of neutralizing epitopes and receptor-binding site in murine coronavirus spike protein","volume":"380","author":"Taguchi","year":"1995","journal-title":"Adv Exp Med Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(04)16255-7","article-title":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome","volume":"363","author":"Cheng","year":"2004","journal-title":"Lancet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev Vaccines."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1128\/jvi.77.19.10515-10527.2003","article-title":"Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase","volume":"77","author":"Brockway","year":"2003","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/3-540-26765-4_2","article-title":"Coronavirus transcription: a perspective","volume":"287","author":"Sawicki","year":"2005","journal-title":"Curr Top Microbiol Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2017_25","article-title":"de Wilde, Eric J, Snijder MK, van HMJ. Host factors in coronavirus replication","volume":"419","author":"Adriaan","year":"2018","journal-title":"Curr Top Microbiol Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1128\/jvi.79.9.5288-5295.2005","article-title":"Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus","volume":"79","author":"Hussain","year":"2005","journal-title":"J Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"14406","DOI":"10.1074\/jbc.RA119.008964","article-title":"The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal","volume":"294","author":"Perrier","year":"2019","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"180","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med."},{"key":"B41","unstructured":"Information for Healthcare Professionals: COVID-19 Underlying Conditions2020"},{"key":"B42","unstructured":"Infection Control: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2020"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12932\/AP-200220-0772","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pacific J allergy Immunol"},{"key":"B44","unstructured":"People Who Are at Higher Risk for Severe Illness | Coronavirus | COVID-192020"},{"key":"B45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3201\/eid1001.030404","article-title":"Severe acute respiratory syndrome-associated coronavirus in lung tissue","volume":"10","author":"Mazzulli","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J Exp Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1056\/NEJMc1210001","article-title":"SARS-CoV-2 Infection in Children","volume":"382","author":"Centis","year":"2020","journal-title":"N Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2139\/ssrn.3602441","article-title":"Vulnerability of children with COVID-19 infection and ACE2 profiles in lungs","volume":"1","author":"Zhang","year":"2020","journal-title":"SSRN."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41390-020-0892-8","article-title":"Possible causes for decreased susceptibility of children to coronavirus","volume":"145","author":"Zhu","year":"2020","journal-title":"Pediatr Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12519-020-00345-5","article-title":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus","volume":"16","author":"Chen","year":"2020","journal-title":"World J Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamapediatrics.2020.1948","article-title":"Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and canadian pediatric intensive care units","volume":"2019","author":"Shekerdemian","year":"2020","journal-title":"JAMA Pediatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2020.05.10.20097394","article-title":"Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France","author":"Toubiana","year":"2020","journal-title":"medRxiv."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.05.058","article-title":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department","author":"Waltuch","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0952-7915(02)00354-0","article-title":"Links between innate and adaptive immunity via type I interferon","volume":"14","author":"Le Bon","year":"2002","journal-title":"Curr Opin Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cytogfr.2008.01.001","article-title":"Interferon and cytokine responses to SARS-coronavirus infection","volume":"19","author":"Thiel","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/vim.2011.0099","article-title":"SARS-CoV regulates immune function-related gene expression in human monocytic cells","volume":"25","author":"Hu","year":"2012","journal-title":"Viral Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CDLI.11.2.362-371.2004","article-title":"Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers","volume":"11","author":"Tan","year":"2004","journal-title":"Clin Diagn Lab Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000075294","article-title":"Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients","volume":"11","author":"Wu","year":"2004","journal-title":"J Biomed Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virusres.2014.03.018","article-title":"Serological assays for emerging coronaviruses : challenges and pitfalls","volume":"194","author":"Meyer","year":"2014","journal-title":"Virus Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM200307313490520","article-title":"Profile of specific antibodies to the SARS-associated coronavirus","volume":"349","author":"Li","year":"2003","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Ka-fai Li","year":"2008","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2 : an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"21","author":"Guo","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042382","article-title":"Viral kinetics and antibody responses in patients with COVID-19","author":"Tan","year":"2020","journal-title":"medRxiv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41423-020-0438-3","article-title":"Protective humoral immunity in SARS-CoV-2 infected pediatric patients","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20944\/preprints202003.0138.v1","article-title":"Medical countermeasures analysis of 2019-nCoV and vaccine risks for antibody-dependent enhancement (ADE)","author":"Ricke","year":"2020","journal-title":"Preprint"},{"key":"B68","first-page":"25","article-title":"Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS","volume":"22","author":"Yip","year":"2016","journal-title":"Hong Kong Med J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1073\/pnas.2005456117","article-title":"Avoiding pitfalls in the pursuit of a COVID-19 vaccine","volume":"117","author":"Peeples","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B71","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1128\/jvi.01464-10","article-title":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic t-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.humimm.2009.05.006","article-title":"Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population","volume":"70","author":"Keicho","year":"2009","journal-title":"Hum Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/JCM.44.2.359-365.2006","article-title":"Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003","volume":"44","author":"Chen","year":"2006","journal-title":"J Clin Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1089\/vim.2011.0024","article-title":"Human-leukocyte antigen class i Cw 1502 and Class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection","volume":"24","author":"Wang","year":"2011","journal-title":"Viral Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/1817-1737.185756","article-title":"Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection","volume":"11","author":"Hajeer","year":"2016","journal-title":"Ann Thorac Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e00165","DOI":"10.1128\/mBio.00165-13","article-title":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","volume":"4","author":"Josset","year":"2013","journal-title":"MBio."},{"key":"B77","doi-asserted-by":"publisher","first-page":"E1012","DOI":"10.1073\/pnas.1706928115","article-title":"MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape","volume":"115","author":"Menachery","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-bourboulis","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.neo.2019.07.002","article-title":"SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression","volume":"21","author":"Alam","year":"2019","journal-title":"Neoplasia (United States)."},{"key":"B80","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1128\/jvi.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1016\/j.vaccine.2007.06.047","article-title":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses","volume":"25","author":"Huang","year":"2007","journal-title":"Vaccine."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aan5393","article-title":"Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses","volume":"2","author":"Zhao","year":"2017","journal-title":"Sci Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virol.2005.11.042","article-title":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens","volume":"347","author":"Gupta","year":"2006","journal-title":"Virology."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2020.02.03.933226","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.virusres.2007.02.014","article-title":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)","volume":"133","author":"Cameron","year":"2008","journal-title":"Virus Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal changes in cytokine\/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome","volume":"11","author":"Chien","year":"2006","journal-title":"Respirology."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment","volume":"94","author":"Lau","year":"2013","journal-title":"J Gen Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J Infect Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"129","author":"Channappanavar","year":"2019","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2015.10.024","article-title":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","volume":"186","author":"Ng","year":"2016","journal-title":"Am J Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virusres.2009.07.014","article-title":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients","volume":"145","author":"Kong","year":"2009","journal-title":"Virus Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"2019","author":"Diao","year":"2020","journal-title":"Front Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Zhe","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19 : consider cytokine storm syndromes and immunosuppression","volume":"6736","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"Anti-inflammation treatment of severe coronavirus disease 2019 (COVID-19): from the perspective of clinical immunologists from China","volume":"214","author":"Wen","year":"2020","journal-title":"Clin Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s2665-9913(20)30137-5","article-title":"Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms","volume":"2","author":"Pain","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B102","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.it.2003.08.006","article-title":"The interferon in TLR signaling: more than just antiviral","volume":"24","author":"Hertzog","year":"2003","journal-title":"Trends Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome:retrospective analysis","volume":"326","author":"Wong","year":"2003"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"189","author":"Li","year":"2004","journal-title":"J Infect Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s13238-013-3096-8","article-title":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists","volume":"4","author":"Yang","year":"2013","journal-title":"Protein Cell."},{"key":"B107","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of","volume":"83","author":"Signaling","year":"2009","journal-title":"J Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J Biol Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/jvi.00367-09","article-title":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein","volume":"83","author":"Freundt","year":"2009","journal-title":"J Virol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/jvi.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J Virol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.01174-14","article-title":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses","volume":"5","author":"Menachery","year":"2014","journal-title":"MBio."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-melo","year":"2020","journal-title":"Cell."},{"key":"B113","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"219","DOI":"10.6026\/97320630016222","article-title":"CoViD-19 immunopathology & immunotherapy","volume":"16","author":"Chiappelli","year":"2020","journal-title":"Bioinformation."},{"key":"B116","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.0105-2896.2006.00381.x","article-title":"CD4+ memory T cells: functional differentiation and homeostasis","volume":"211","author":"Stockinger","year":"2006","journal-title":"Immunol Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2567.2010.03288.x","article-title":"Generation, persistence and plasticity of CD4 T-cell memories","volume":"130","author":"Lees","year":"2010","journal-title":"Immunology."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch Virol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.virol.2006.03.036","article-title":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients","volume":"351","author":"Peng","year":"2006","journal-title":"Virology."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity."},{"key":"B122","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B123","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40779-020-0233-6","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B126","doi-asserted-by":"publisher","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci Transl Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/S2665-9913(20)30092-8","article-title":"Preventing COVID-19-induced pneumonia with anticytokine therapy","volume":"2","author":"Monteleone","year":"2020","journal-title":"The Lancet Rheumatogy"},{"key":"B129","unstructured":""},{"key":"B130","unstructured":"Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-192020"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antiviral Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e20200653","DOI":"10.1084\/jem.20200653","article-title":"COVID-19 and emerging viral infections: the case for interferon lambda","volume":"217","author":"Prokunina-Olsson","year":"2020","journal-title":"J Exp Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/VAAT.S12733","article-title":"Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease","volume":"2","author":"Ortiz-Alcantara","year":"2010","journal-title":"Virus Adapt Treat."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"5883","author":"Sheahan","year":"2020","journal-title":"Sci Transl Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/nejmoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"12250","DOI":"10.1007\/s12250-020-00204-7","article-title":"Old weapon for new enemy: drug repurposing for treatment of newly emerging viral diseases","volume":"35","author":"Guo","year":"2020","journal-title":"Virol Sin."},{"key":"B141","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature."},{"key":"B144","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B145","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B146","unstructured":"The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection2020"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-6-8","article-title":"Molecular mechanisms of severe acute respiratory syndrome (SARS)","volume":"6","author":"Groneberg","year":"2005","journal-title":"Respir Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci Rep."},{"key":"B150","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aau9242","article-title":"Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge","volume":"11","author":"Lo","year":"2019","journal-title":"Sci Transl Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Preliminary Report","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/asia.201900841","article-title":"New nucleoside analogues for the treatment of hemorrhagic fever virus infections","volume":"14","author":"De Clercq","year":"2019","journal-title":"Chem - An Asian J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijpddr.2018.10.002","article-title":"Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity","volume":"8","author":"Aguiar","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J."},{"key":"B157","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19","author":"Boulware","year":"2020","journal-title":"N Engl J Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials."},{"key":"B160","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1128\/jvi.79.11.7095-7103.2005","article-title":"Cinanserin is an inhibitor of the 3c-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J Enzyme Inhib Med Chem."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1248\/bpb.b12-00623","article-title":"Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus","volume":"35","author":"Park","year":"2012","journal-title":"Biol Pharm Bull."},{"key":"B163","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3201\/eid2209.151164","article-title":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia","volume":"22","author":"Arabi","year":"2016","journal-title":"Emerg Infect Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou","year":"2007","journal-title":"N Engl J Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1172\/jci138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"B167","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med."},{"key":"B168","doi-asserted-by":"publisher","first-page":"202004168","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B169","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B170","unstructured":"Recommendations for Investigational COVID-19 Convalescent Plasma2020"},{"key":"B171","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1586\/erv.09.43","article-title":"SARS vaccines: where are we?","volume":"8","author":"Roper","year":"2009","journal-title":"Expert Rev Vaccines."},{"key":"B172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1348-0421.2008.00097.x","article-title":"Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model","volume":"53","author":"Ishii","year":"2009","journal-title":"Microbiol Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.virol.2004.04.017","article-title":"SARS corona virus peptides recognized by antibodies in the sera of convalescent cases","volume":"324","author":"Guo","year":"2004","journal-title":"Virology."},{"key":"B174","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/rmv.492","article-title":"Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine","volume":"16","author":"Tsunetsugu-Yokota","year":"2006","journal-title":"Rev Med Virol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science."},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.093195","article-title":"ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques","author":"van Doremalen","year":"2020","journal-title":"bioRxiv."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"6736","author":"Zhu","year":"2020","journal-title":"Lancet."},{"key":"B179","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1128\/jvi.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS ONE."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1128\/jvi.00983-14","article-title":"Effects of toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine","volume":"2","author":"Iwata-Yoshikawa","year":"2014","journal-title":"J Virol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2020.04.023","article-title":"Identification of human single-domain antibodies against SARS-CoV-2","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B187","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.ebiom.2020.102743","article-title":"Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development","volume":"55","author":"Kim","year":"2020","journal-title":"EBioMedicine."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat Fatima","year":"2020","journal-title":"Cell."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.23812\/20-Editorial-Kritas","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","author":"Kritas","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B191","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B192","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","article-title":"A phase 3, single-arm, prospective study of remestemcel-l, ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1517\/14712598.2011.602967","article-title":"Remestemcel-L: Human mesenchymal stem cells as an emerging therapy for Crohn's disease","volume":"11","author":"Mannon","year":"2011","journal-title":"Expert Opin Biol Ther."},{"key":"B194","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"B195","first-page":"2060","volume-title":"Mesoblast To Evaluate Anti-Inflammatory Cell Therapy Remestemcel-L for Treatment of Covid-19 Lung Disease","year":"2020"},{"key":"B196","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01949\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:41:42Z","timestamp":1596760902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01949\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":196,"alternative-id":["10.3389\/fimmu.2020.01949"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01949","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"article-number":"1949"}}